Status: Recruiting
Molecular and Structural Imaging in Alzheimer's Disease: A Longitudinal Study
This is a neuroimaging study designed to learn more about amyloid and tau burden in the brain of patients with typical and atypical Alzheimer's Disease and how burden may change over a one year period.
Participants needed: 60
Trial details
Age: 21-80Biological sex: AllType: InterventionalSponsor: Mayo ClinicUpdated: Jul 17, 2026Locations: 1
Eligibility criteria
Over the age of 21 [+5]
If you have had a stroke or tumor that could explain your symptoms [+6]